Wilkinson PM - Search Results

1

Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.

de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Fosså SD, Cook P, de Prijck L, Stenning S, Collette L. de Wit R, et al. Among authors: wilkinson pm. J Clin Oncol. 2001 Mar 15;19(6):1629-40. doi: 10.1200/JCO.2001.19.6.1629. J Clin Oncol. 2001. PMID: 11250991 Clinical Trial.

2

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.

Mead GM, Stenning SP, Parkinson MC, Horwich A, Fossa SD, Wilkinson PM, Kaye SB, Newlands ES, Cook PA. Mead GM, et al. Among authors: wilkinson pm. J Clin Oncol. 1992 Jan;10(1):85-94. doi: 10.1200/JCO.1992.10.1.85. J Clin Oncol. 1992. PMID: 1309383

3

Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party.

Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fossa SD, Horwich A, Jones WG, Newlands ES, Oliver RT, Stenwig AE, Wilkinson PM. Stenning SP, et al. Among authors: wilkinson pm. Cancer. 1998 Oct 1;83(7):1409-19. Cancer. 1998. PMID: 9762943

4

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.

Fosså SD, Stenning SP, Gerl A, Horwich A, Clark PI, Wilkinson PM, Jones WG, Williams MV, Oliver RT, Newlands ES, Mead GM, Cullen MH, Kaye SB, Rustin GJ, Cook PA. Fosså SD, et al. Among authors: wilkinson pm. Br J Cancer. 1999 Jul;80(9):1392-9. doi: 10.1038/sj.bjc.6690534. Br J Cancer. 1999. PMID: 10424741 Free PMC article.

5

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.

Horwich A, Oliver RT, Wilkinson PM, Mead GM, Harland SJ, Cullen MH, Roberts JT, Fossa SD, Dearnaley DP, Lallemand E, Stenning SP; MRC Testicular Tumour Working Party. Horwich A, et al. Among authors: wilkinson pm. Br J Cancer. 2000 Dec;83(12):1623-9. doi: 10.1054/bjoc.2000.1498. Br J Cancer. 2000. PMID: 11104556 Free PMC article. Clinical Trial.

6

Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.

Radford JA, Crowther D, Rohatiner AZ, Ryder WD, Gupta RK, Oza A, Deakin DP, Arnott S, Wilkinson PM, James RD, et al. Radford JA, et al. Among authors: wilkinson pm. J Clin Oncol. 1995 Sep;13(9):2379-85. doi: 10.1200/JCO.1995.13.9.2379. J Clin Oncol. 1995. PMID: 7666097 Clinical Trial.

7

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.

Pettengell R, Radford JA, Morgenstern GR, Scarffe JH, Harris M, Woll PJ, Deakin DP, Ryder D, Wilkinson PM, Crowther D. Pettengell R, et al. Among authors: wilkinson pm. J Clin Oncol. 1996 Feb;14(2):586-92. doi: 10.1200/JCO.1996.14.2.586. J Clin Oncol. 1996. PMID: 8636775 Clinical Trial.

8

High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: an effective first-line therapy with minimal toxicity.

Decatris MP, Wilkinson PM, Welch RS, Metzner M, Morgenstern GR, Dougall M. Decatris MP, et al. Among authors: wilkinson pm. Ann Oncol. 2000 Apr;11(4):427-34. doi: 10.1023/a:1008393512723. Ann Oncol. 2000. PMID: 10847461 Free article.

9

ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.

Radford JA, Rohatiner AZ, Ryder WD, Deakin DP, Barbui T, Lucie NP, Rossi A, Dunlop DJ, Cowan RA, Wilkinson PM, Gupta RK, James RD, Shamash J, Chang J, Crowther D, Lister TA. Radford JA, et al. Among authors: wilkinson pm. J Clin Oncol. 2002 Jul 1;20(13):2988-94. doi: 10.1200/JCO.2002.11.107. J Clin Oncol. 2002. PMID: 12089229 Clinical Trial.

10

Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.

Weaver A, Chang J, Wrigley E, de Wynter E, Woll PJ, Lind M, Jenkins B, Gill C, Wilkinson PM, Pettengell R, Radford JA, Collins CD, Dexter TM, Testa NG, Crowther D. Weaver A, et al. Among authors: wilkinson pm. J Clin Oncol. 1998 Aug;16(8):2601-12. doi: 10.1200/JCO.1998.16.8.2601. J Clin Oncol. 1998. PMID: 9704709 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page